Back to Search Start Over

Dysregulation of Transcription Factor Networks Unveils Different Pathways in Human Papillomavirus 16-Positive Squamous Cell Carcinoma and Adenocarcinoma of the Uterine Cervix.

Authors :
Bispo S
Farias TDJ
de Araujo-Souza PS
Cintra R
Dos Santos HG
Jorge NAN
Castro MAA
Wajnberg G
Scherer NM
Genta MLND
Carvalho JP
Villa LL
Sichero L
Passetti F
Source :
Frontiers in oncology [Front Oncol] 2021 May 19; Vol. 11, pp. 626187. Date of Electronic Publication: 2021 May 19 (Print Publication: 2021).
Publication Year :
2021

Abstract

Squamous cell carcinoma (SCC) and adenocarcinoma (ADC) are the most common histological types of cervical cancer (CC). The worse prognosis of ADC cases highlights the need for better molecular characterization regarding differences between these CC types. RNA-Seq analysis of seven SCC and three ADC human papillomavirus 16-positive samples and the comparison with public data from non-tumoral human papillomavirus-negative cervical tissue samples revealed pathways exclusive to each histological type, such as the epithelial maintenance in SCC and the maturity-onset diabetes of the young (MODY) pathway in ADC. The transcriptional regulatory network analysis of cervical SCC samples unveiled a set of six transcription factor (TF) genes with the potential to positively regulate long non-coding RNA genes DSG1-AS1, CALML3-AS1, IGFL2-AS1 , and TINCR . Additional analysis revealed a set of MODY TFs regulated in the sequence predicted to be repressed by miR-96-5p or miR-28-3p in ADC. These microRNAs were previously described to target LINC02381, which was predicted to be positively regulated by two MODY TFs upregulated in cervical ADC. Therefore, we hypothesize LINC02381 might act by decreasing the levels of miR-96-5p and miR-28-3p, promoting the MODY activation in cervical ADC. The novel TF networks here described should be explored for the development of more efficient diagnostic tools.<br />Competing Interests: LLV is speaker and consultant of Merck Sharp & Dohme for HPV prophylactic vaccines. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2021 Bispo, Farias, de Araujo-Souza, Cintra, Santos, Jorge, Castro, Wajnberg, Scherer, Genta, Carvalho, Villa, Sichero and Passetti.)

Details

Language :
English
ISSN :
2234-943X
Volume :
11
Database :
MEDLINE
Journal :
Frontiers in oncology
Publication Type :
Academic Journal
Accession number :
34094909
Full Text :
https://doi.org/10.3389/fonc.2021.626187